Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis
This study is currently recruiting participants.
Verified November 2012 by Teva Pharmaceuticals USA
Sponsor:
Teva Pharmaceuticals USA
Information provided by (Responsible Party):
Teva Pharmaceuticals USA
ClinicalTrials.gov Identifier:
NCT01686152
First received: September 12, 2012
Last updated: November 9, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2013 |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |